EPA Accepts Clorox Germicidal Wipes for C. Diff.

The Clorox Company says the US Environmental Protection Agency (EPA) has accepted the registration of Clorox Commercial Solutions Clorox Germicidal Wipes to kill Clostridium difficile (C. difficile) spores in five minutes.


Clorox announced the news today at the Association for Professionals in Infection Control and Epidemiology (APIC) annual meeting.


Clorox Germicidal Wipes, which are ready-to-use, hospital-grade disinfectant wipes, exceed the Centers for Disease Control and Prevention (CDC) recommended requirement to kill many of the pathogens of most concern to hospitals. Clorox Germicidal Wipes are equal to a 1:10 dilution of liquid bleach and include an odor-masking agent, specially formulated to provide fast, effective disinfecting to accommodate the most sensitive environments and users.


“The EPA registration reinforces Clorox’s commitment to reducing the spread of infections and disease-causing pathogens, such as C. difficile, while providing useful and important tools to the healthcare community,” said Craig Stevenson, vice president and general manager, Clorox Professional Products Company. “Clorox Germicidal Wipes provide a fast, highly effective way to help keep the patient environment disinfected and is an excellent addition to Clorox’s comprehensive products to kill C. difficile spores.”


The Clorox Germicidal Wipes EPA registration comes just months after the company’s March announcement that its Dispatch Hospital Cleaner Disinfectant Towels received EPA registration for C. difficile spores.